Coating of Mannan on LPD Particles Containing HPV E7 Peptide Significantly Enhances Immunity Against HPV-Positive Tumor (original) (raw)
References
N. Renkvist, C. Castelli, P. F. Robbins, and G. Parmiani. A listing of human tumor antigens recognized by T cells. Cancer Immunol. Immunother.50:3-15 (2001). Google Scholar
G. Parmiani, M. Sensi, C. Castelli, L. Rivoltini, and A. Anichini. T-cell response to unique and shared antigens and vaccination of cancer patients. Cancer Immun.2:6-15 (2002). Google Scholar
G. Ada Vaccines and vaccination. N. Engl. J. Med.345:1042-1053 (2001). Google Scholar
L. Fong and E. G. Engleman. Dendritic cells in cancer immunotherapy. Annu. Rev. Immunol.18:245-273 (2000). Google Scholar
S. Li and L. Huang. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther.4:891-900 (1997). Google Scholar
S. Li, M. A. Rizzo, S. Bhattacharya, and L. Huang. Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery. Gene Ther.5:930-937 (1998). Google Scholar
M. S. Whitmore, S. Li, and L. Huang. LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth. Gene Ther.6:1867-1875 (1999). Google Scholar
M. Whitmore. Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses. Cancer Immunol. Immunother.50:503-14 (2001). Google Scholar
J. Dileo, R. Banerjee, M. Whitmore, J. V. Nayak, L. FaloJr., and L. Huang. Lipid-protamine-DNA-mediated antigen delivery to antigen-presenting cells results in enhanced anti-tumor immune responses. Mol. Ther.7:640-648 (2003). Google Scholar
A. F. Ochsenbein, P. Klenerman, U. Karrer, B. Ludewig, M. Pericin, H. Hengartner, and R. Zinkernagel. Immune surveillance against a solid tumor fails because of immunological ignorance. Proc. Natl. Acad. Sci. USA96:2233-2238 (1999). Google Scholar
R. Zinkernagel, S. Ehl, P. Aichele, S. Oehen, T. Kundig, and H. Hengartner. Antigen localisation regulates immune responses in a dose-and time-dependent fashion: a geographical view of immune reactivity. Immunol. Rev.156:199-209 (1997). Google Scholar
O. Akbari, N. Panjwani, S. Garcia, R. Tascon, D. Lowrie, and B. Stockinger. DNA vaccination: transfection and activation of dendritic cells as key events for immunity. J. Exp. Med.189:169-178 (1999). Google Scholar
C. Condon. S. watkins, C. Celluzzi, K. Thompson, L. Falo, Jr. DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med.2:1122-1128 (1996). Google Scholar
A. Porgador, K. Irvine, A. Iwasaki, B. Barber, N. Restifo, and R. Germain. Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization. J. Exp. Med.188:1075-1082 (1998). Google Scholar
U. Karrer, A. Althage, B. Odermatt, C. Roberts, S. Korsmeyer, S. Miyawaki, H. Hengartner, and R. M. Zinkernagel. On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly/aly) and spleenless (Hox11(-)/-) mutant mice. J. Exp. Med.185:2157-2170 (1997). Google Scholar
A. Avrameas, D. McIlroy, A. Hosmalin, B. Autran, P. Debre, M. Monsigy, A. C. Roche, P. Midoux. Expression of a mannose/fucose membrane lectin on human dendritic cells. Eur. J. Immunol.26:394-400 (1996). Google Scholar
I. McKenzie, V. Apostolopoulos, C. Lees, P. Xing, S. Lofthouse, C. Osinski, V. Popouski, B. Acres, G. Pietersz. Oxidised mannan antigen conjugates preferentially stimulate T1 type immune responses. Vet. Immunol. Immunopathol.63:185-190 (1998). Google Scholar
M. Fukasawa, Y. Shimizu, K. Shikata, M. Nakata, R. Sakakibara, N. Yamamoto, M. Hatanaka, T. Mizuochi. Liposome oligomannose-coated with neoglycolipid, a new candidate for a safe adjuvant for induction of CD8+ cytotoxic T lymphocytes. FEBS Lett.441:353-356 (1998). Google Scholar
V. Apostolopoulos, N. Barnes, G. Pietersz, and I. McKenzie. Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses. Vaccine18:3174-3184 (2000). Google Scholar
M. Gadjeva, S. Thiel, and J. C. Jensenius. The mannan-binding-lectin pathway of the innate immune response. Curr. Opin. Immunol.13:74-78 (2001). Google Scholar
N. Okada, T. Saito, K. Mori, Y. Masunag, Y. Fujii, J. Fujita, K. Fujimoto, T. Nakanishi, K. Tanaka, S. Nakagawa, T. Mayumi, T. Fujita, A. Yamamoto. Effects of lipofectin-antigen complexes on major histocompatibility complex class I-restricted antigen presentation pathway in murine dendritic cells and on dendritic cell maturation. Biochim. Biophys. Acta1527:97-101 (2001). Google Scholar
S. Toda, N. Ishii, E. Okada, K. Kusakabe, H. Arai, K. Hamajima, I. Gorai, K. Nishioka, K. Okuda. HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-gamma antibody. Immunology92:111-117 (1997). Google Scholar
Z. Cui and R. J. Mumper. Topical immunization using nanoengineered genetic vaccines. J. Control. Rel.81:173-184 (2002). Google Scholar
J. C. Brown and R. C. Hunt. Lectins. Int. Rev. Cytol.52:277-349 (1978). Google Scholar
M. Dittgen and B. Herbst. Zeta potential—fundamentals, measurement methods and application to pharmacy. Pharmazie42:641-656 (1987). Google Scholar
L. East and C. M. Isacke. The mannose receptor family. Biochim. Biophys. Acta1572:364-386 (2002). Google Scholar
C. Howard, J. Hope, S. Stephens, D. Gliddon, and G. Brooke. Co-stimulation and modulation of the ensuing immune response. Vet. Immunol. Immunopathol.87:123-130 (2002). Google Scholar
S. M. Moghimi, A. E. Hawley, N. M. Christy, T. Gray, L. Illum, and S. S. Davis. Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes. FEBS Lett.344:25-30 (1994). Google Scholar
T. Nakanishi, J. Kunisawa, A. Hayashi, Y. Tsutsumi, K. Kubo, S. Nakagawa, H. Fujiwara, T. Hamaoka, T. Mayumi. Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins. Biochem. Biophys. Res. Commun.240:793-797 (1997). Google Scholar
W. Jiang and D. S. Pisetsky. Enhancing immunogenicity by CpG DNA. Curr. Opin. Mol. Ther.5:180-185 (2003). Google Scholar
B. Li, S. Li, T. Tan, D. B. Stolz, S. Watkins, L. Block, and L. Huang. Lyophilization of cationic lipid-protamine-DNA (LPD) complexes. J. Pharm. Sci.89:355-364 (2000). Google Scholar